BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05232916-completion@plaintrial.com
DTSTAMP:20260926T055246Z
DTSTART;VALUE=DATE:202612
SUMMARY:Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Pepti
 de GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects — estimated com
 pletion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT05232916
URL:https://plaintrial.com/trial/NCT05232916
END:VEVENT
END:VCALENDAR